Apexigen, Inc.
APGNDelisted Aug 23, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001814140
Apexigen, Inc. was delisted on Aug 23, 2023; its insiders filed their last Form 4 on Aug 25, 2023; 17 institutions reported holding it in 13F filings for Q2 2023, worth $1.37M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Apexigen, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 1 | 17 | +16 |
| Shares | 89.7K | 3.14M | +3.05M (+3,401.1%) |
| Value | $912.0K | $8.48M | +$7.57M (+830.0%) |
New holders (17)
Institutions that held Apexigen, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 1,894,551 | $5.12M | 1.85% |
| Fan Yu | 401,757 | $1.08M | 14.78% |
| Vanguard Group Inc | 256,555 | $692.0K | 0.00% |
| BlackRock Inc. | 213,833 | $577.0K | 0.00% |
| Geode Capital Management, LLC | 179,140 | $483.0K | 0.00% |
| State Street Corp | 54,300 | $147.0K | 0.00% |
| Citadel Advisors LLC | 52,390 | $141.0K | 0.00% |
| Jane Street Group, LLC | 34,421 | $93.0K | 0.00% |
| Northern Trust Corp | 31,041 | $84.0K | 0.00% |
| Two Sigma Investments, LP | 13,934 | $38.0K | 0.00% |
| UBS Group AG | 7,962 | $22.0K | 0.00% |
| Fifth Third Bancorp | 1,500 | $4.00K | 0.00% |
| Advisor Group Holdings, Inc. | 200 | $1.00K | 0.00% |
| Wells Fargo & Company | 124 | $0 | 0.00% |
| Morgan Stanley | 49 | $0 | 0.00% |
| Simplex Trading, LLC | 196 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 117 | $0 | 0.00% |
Sold out (1)
Institutions that held Apexigen, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Tudor Investment Corp Et Al | 89,746 | $912.0K |